Newsletter | Pharma, Healthcare and Life Sciences

In Private ruling No. 151/2022, the Italian Tax Authority provided new guidelines on direct and indirect taxes applicable to an asset purchase relating to a pharmaceutical product. Our professionals from the Practice Area Pharma, Healthcare and Life sciences reviewed these guidelines, highlighting certain issues that may arise in these transactions.